Otto H. York Department of Chemical and Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102-1982, USA.
Analytical Science, Merck & Co., Inc, Rahway, NJ 07065-0900, USA.
Int J Pharm. 2021 Sep 25;607:120976. doi: 10.1016/j.ijpharm.2021.120976. Epub 2021 Aug 4.
The USP Apparatus 1 (rotating basket), typically used to assess drug product reproducibility and evaluate oral solid dosage forms performance, consists of a cylindrical glass vessel with a hemispherical bottom and a wire basket rotating at constant speed. Baskets with different wire openings can be used in alternative to the standard mesh opening (40-mesh) in order to discriminate between drug formulations during early stage of drug product development. Any changes introduced by different basket geometries can potentially and significantly impact the system hydrodynamics and cause variability of results, thus affecting product quality. In this work, Particle Image Velocimetry (PIV) was used to experimentally quantify the velocity distribution in the USP rotating basket Apparatus 1 using baskets of different mesh sizes (10-, 20-, and 40-mesh size) under the typical operating conditions described in dissolution testing procedures. Similar flow patterns were observed in all cases. However, the radial and axial velocities in the USP Apparatus 1 generally increased with increasingly larger openings of the basket mesh. Increasing the basket agitation speed also resulted in an overall increase in the velocities, especially below in the innermost core region below the basket, where drug fragments typically reside. More importantly, the flow entering and leaving the baskets was quantified from the velocity profiles in the immediate vicinity of the baskets. It was found that the flow increased significantly with increasingly larger mesh openings, which can, in turn, promote faster dissolution of the oral solid dosage forms, thus affecting drug dissolution profiles. Hence, the selection of the basket mesh size must be carefully considered during drug product development.
USP 装置 1(旋转篮)通常用于评估药物产品的重现性和评估口服固体制剂的性能,它由一个圆柱形玻璃容器组成,底部为半球形,篮筐以恒定速度旋转。可以使用不同线孔的篮筐替代标准网孔(40 目),以便在药物产品开发的早期阶段区分药物配方。不同篮筐几何形状引入的任何变化都可能显著影响系统流体动力学并导致结果的可变性,从而影响产品质量。在这项工作中,使用粒子图像测速法(PIV)在溶解试验程序中描述的典型操作条件下,使用不同网孔尺寸(10 目、20 目和 40 目)的篮筐实验定量测量 USP 旋转篮装置 1 中的速度分布。在所有情况下都观察到了相似的流动模式。然而,USP 装置 1 中的径向和轴向速度通常随着篮筐网孔尺寸的增大而增大。增加篮筐搅拌速度也会导致速度总体增加,特别是在篮筐下方的最内层核心区域,药物碎片通常存在于该区域。更重要的是,从篮筐附近的速度分布中定量了进出篮筐的流量。结果发现,流量随着网孔尺寸的增大而显著增加,这反过来又可以促进口服固体制剂更快地溶解,从而影响药物溶解曲线。因此,在药物产品开发过程中,必须仔细考虑篮筐网孔尺寸的选择。